Principia Biopharma

Principia Biopharma

Principia Biopharma

Principia Biopharma is focused on the R&D of differentiated small molecule drugstargeting inflammatory and autoimmune diseases, and cancer.
Raised
$168.8M
Follow us
Alexa global traffic share
Latest funding Show all
$106,250,000
IPO - 2018
$50,000,000
Venture capital (Series B) - 2014
Morgenthaler Ventures New Leaf Venture Partners SR One +3
Team Size
10+
Employees
$106,250,000 IPO
PE HUB

VC-backed Principia Biopharma debuts IPO

Xconomy

Entasis Therapeutics and Principia Biopharma Join the IPO Queue